Microsatellite alterations in esophageal dysplasia and squamous cell carcinoma from laser capture microdissected endoscopic biopsies

Cancer Letters

Volumn 189, Issue 2, 2003, Pages 137-145

  Lu, Ning ^a   Hu, Nan ^b   Li, Wen Jun ^c   Roth, Mark J ^b   Wang, Chaoyu ^b   Su, Hua ^d   Wang, Quan Hong ^c   Taylor, Philip R ^b   Dawsey, Sanford M ^b  

^a CANCER HOSPITAL   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SHANXI CANCER HOSPITAL   (China)

^d NATIONAL VACCINE AND SERUM INSTITUTE   (China)

Author keywords

Allelic loss; Esophageal cancer; Microdissection; Precursor lesion

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPLASIA; ENDOSCOPIC BIOPSY; ESOPHAGUS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LASER; MALE; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BIOPSY; CARCINOMA, SQUAMOUS CELL; CHINA; ESOPHAGEAL DISEASES; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; GENETIC MARKERS; HUMANS; LASERS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS;

EID: 0037469102     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00555-4     Document Type: Article

References (28)

1. Li M.H., Li P., Li P.J. Recent progress in research on esophageal cancer in China. Adv. Cancer Res. 33:1980;173-249.
2. Li J.Y. Epidemiology of esophageal cancer in China. NCI Monogr. 62:1982;113-120.
3. Hu N., Roth M.J., Polymeropolous M., Tang Z.Z., Emmert-Buck M.R., Wang Q.H., Goldstein A.M., Feng S.S., Dawsey S.M., Ding T., Zhuang Z.P., Han X.Y., Reid T., Giffen C., Taylor P.R. Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population. Genes Chromosomes Cancer. 27:2000;217-228.
4. Hu N., Roth M.J., Emmert-Buck M.R., Tang Z.Z., Polymeropolous M., Wang Q.H., Goldstein A.M., Han X.Y., Dawsey S.M., Ding T., Giffen C., Taylor P.R. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. Clin. Cancer Res. 5:1999;3476-3482.
5. Roth M.J., Hu N., Emmert-Buck M.R., Wang Q.H., Dawsey S.M., Li G., Guo W.J., Zhang Y.Z., Taylor P.R. Genetic progression and heterogeneity associated with development of esophageal squamous cell carcinoma. Cancer Res. 61:2001;4098-4104.
6. Dawsey S.M., Lewin K.J., Path F.R.C., Wang G.Q., Liu F.S., Neiberg R.K., Yu Y., Li J.Y., Blot W.J., Li B., Taylor P.R. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus: a prospective follow-up study from Linxian, China. Cancer. 74:1994;1686-1692.
7. Dawsey S.M., Lewin K.J., F S., Liu G.Q., Wang Q. Esophageal morphology from Linxian, China: squamous histologic findings in 754 patients. Cancer. 73:1994;2027-2037.
8. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., Weiss R.A., Liotta L.A. Laser capture microdissection. Science. 274:1996;998-1001.
9. Aoki T., Mori T., Du X., Nisihira T., Matsubara T., Nakamaua Y. Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer. 10:1994;177-182.
10. Montesano R., Hollstein M., Hainaut P. Genetic alterations in esophageal cancer in their relevance to etiology and pathogenesis: a review. Int. J. Cancer. 69:1996;225-235.
11. Romagnoli S., Roncalli M., Graziani D., Cassani B., Roz E., Bonavina L., Peracchia A., Bosari S., Coggi G. Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies. Lab. Invest. 18:2001;241-247.
12. Nowell P.C. The clonal evolution of tumor cell populations. Science. 194:1976;23-28.
13. O'Connell P., Pekkel V., Fuqua S.A., Osborne C.K., Clark G.M., Allred D.C. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J. Natl. Cancer Inst. 90:1998;697-703.
14. Wu T.T., Watanabe T., Heitmiller R., Zahurak M., Forastiere A.A., Hamilton S.R. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am. J. Pathol. 153:1998;287-294.
15. Barrett M., Sanchez C.A., Prevo L., Wong D.J., Galipeau P.C., Paulson T.G., Rabinovitch P.S., Reid B.J. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat. Genet. 22:1999;106-109.
16. Wistuba I.I., Behrenes C., Michgrub S., Bryant D., Hung J., Minna J.D., Gazdar A.F. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 18:1999;643-650.
17. Mori T., Yanagisuwa A., Kato Y., Muria K., Nishihira T., Mori S., Nakamura Y. Accumulation of genetic alterations during esophageal carcinogenesis. Hum. Mol. Genet. 3:1994;1969-1971.
18. Mori T., Miura K., Aoki T., Nishihira T., Mori S., Nakamura Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/Cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54:1994;3396-3397.
19. Zhou X.L., Tarmin L., Yin J., Jiang H.Y., Suzuki H., Rhyu M.G., Abraham J.M., Meltzer S. The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene. 9:1994;3737-3741.
20. Emmert-Buck M.R., Gillespie J.W., Paweletz C.P., Ornstein D.K., Basrur V., Appella F., Wang Q.H., Huang J., Hu N., Taylor P., Petricoin E.F. III. An approach to proteomic analysis of human tumors. Mol. Carcinog. 27:2000;158-165.
21. Hu N., Li G., Li W.J., Wang C.Y., Goldstein A.M., Tang Z.Z., Roth M.J., Dawsey S.M., Huang J., Wang Q.H., Ding T., Giffen C., Taylor P.R., Emmert-Buck M.R. Infrequent mutation in the BRCA2 gene in esophageal squamous cell carcinoma. Clin. Cancer Res. 8:2002;1121-1126.
22. Chen L., Matsubara N., Yoshino T., Nagasaka T., Hoshizima N., Shirakawa Y., Naomoto Y., Isozaki H., Riabowol K., Tanaka N. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer. Cancer Res. 61:2001;4345-4349.
23. Hu H., Huang J., Emmert-Buck M.R., Tang Z.Z., Roth M.J., Wang C.Y., Dawsey S.M., Li G., Li W.J., Wang Q.H., Han X.Y., Ding T., Giffen C., Goldstein A.M., Taylor P.R. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin. Cancer Res. 7:2001;883-891.
24. Yamano M., Fujii H., Takagaki T., Kadowaki N., Watanabe H., Shirai T. Genetic progression and divergence in pancreatic carcinoma. Am. J. Pathol. 156:2000;2123-2133.
25. Muzeau F., Flejou J.F., Belghiti J., Thomas G., Hamelin R. Infrequent microsatellite instability in oesophageal cancers. Br. J. Cancer. 75:1997;1336-1339.
26. Kagawa Y., Yoshida K., Hirai T., Toge T., Yokozaki H., Yasui W., Tahara E. Microsatellite instability in squamous cell carcinoma and dysplasia of the esophagus. Anticancer Res. 20:2000;213-217.
27. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., Meltzer S.J., Rodrigues-Bigas M.A., Fodde R., Ranzani G.N., Srivastava S.A. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58:1998;5248-5257.
28. Atkin S.B. Microsatellite instability. Cytogenet. Cell Genet. 92:2001;177-181.